OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 146 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,300,000 | -69.1% | 4,086,988 | -5.5% | 0.00% | -75.0% |
| Q4 2015 | $7,438,000 | -18.5% | 4,324,500 | 0.0% | 0.00% | -20.0% |
| Q3 2015 | $9,125,000 | -46.5% | 4,324,500 | +25.5% | 0.01% | -37.5% |
| Q2 2015 | $17,058,000 | -36.8% | 3,446,000 | 0.0% | 0.01% | -33.3% |
| Q1 2015 | $26,982,000 | +24.5% | 3,446,000 | -3.6% | 0.01% | +20.0% |
| Q4 2014 | $21,669,000 | +26.5% | 3,575,800 | -11.1% | 0.01% | +25.0% |
| Q3 2014 | $17,129,000 | -24.1% | 4,020,877 | +10.1% | 0.01% | -20.0% |
| Q2 2014 | $22,566,000 | -13.8% | 3,651,477 | -9.3% | 0.01% | -16.7% |
| Q1 2014 | $26,182,000 | +100.1% | 4,027,977 | +73.3% | 0.01% | +100.0% |
| Q4 2013 | $13,087,000 | +7.3% | 2,324,500 | +17.1% | 0.01% | 0.0% |
| Q3 2013 | $12,192,000 | +33.1% | 1,985,700 | +26.8% | 0.01% | +20.0% |
| Q2 2013 | $9,158,000 | – | 1,565,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |